Professional Documents
Culture Documents
HOSPICE CARE
Latin word hospes - stranger
Hospitalis - friendly, welcome
to the stranger
Hospitium - warm feeling
between guest and a host
Hospice
HOSPICE CARE
Medieval Hospice
St. Christophers
Hospice
Catholic Hospice
goals...
Offers a support system to
help the patient live as
actively as possible until
death
Offers a support system to
help the family cope during
the patients illness and in
their own bereavement
The Names
Palliative Care
when cure is no longer possible
aims to control symptoms and
sometimes to prolong life
ex. Palliative chemo, palliative surgery
Hospice Care
Is a compassionate caring for the
terminally ill patients
Aim is comfort and quality of life
Does not prolong life
Terminal Care
refers to the last stages of an
illness when support for the
family may become especially
important
are generally used
interchangeably though can
give each a particular emphasis
curative
Palliative
Palliative Care Approach
curative
palliative
Terminal Phase
Period of inexorable and irreversible
decline in functional status prior to
death.
May unfold gradually over days or weeks
Fluctuating but ongoing decline in a
progressive illness
GOALS REDEFINED
Regular assessment for new causes of
suffering for both patient and the relatives
GOALS REDEFINED
Changing goals for each stage
Decision making depends on the stage
the patient is in.
Along the continuum of evolving disease
Corresponding change in clinical goals
Moments reached when it is clinically,
ethically justified to withhold or
discontinue clinical treatments
Intermediate
Late/
Terminal Phase
DEATH
Early years
Intermediate months
Late weeks
Terminal phase few days to hours
Definition
1. Initial (Pretrajectory)
3.Crisis
A potentially life-threatening
situation
occurs (eg, a condition requiring
emergency care)
4. Acute
5. Stable
6. Unstable
.7. Downward
8. Dying
HOME CARE
may provoke
agonizing discussions
& difficult decisions
Clinical Challenges
in the Terminal Phase
Compromised
oral intake
IRREVERSIBLE CAUSES
Part of profound generalized
weakness seen during the end of life
Progressive physiologic decline
Mechanical dysphagia due to
obstruction by underlying tumors
enlarged lymphadenopathies.
Withdrawing/Witholding
Food and Fluid Intake
Food and water are widely held symbols of
caring
Withholding of artificial nutrition and hydration
may be easily misperceived as neglect by the
patient, family or other caregivers.
Patients, family members, and caregivers need
a lot of support as well as careful and thorough
explanation why they can do without feeding
the patient during in the terminal phase.
Medications
Review of all medications being taken
Review of medications that might be
needed
Review of how much assistance and
instruction relatives might need in giving
medications if the patient is at home
MANAGEMENT OF PATIENTS
IN THE FINAL DAYS OF LIFE
1. Profoundly weak
2. Essentially bedbound
3. Drowsy for an extended period of time
4. Disoriented with regards to time with severely limited
attention span
5. Increasingly uninterested to food and fluid
6. Finding it difficult to swallow medication
* Not found in books Communicates with dead loved ones
Investigations
Investigations at the end of life should
have a clear & justifiable purpose
Little need for investigations in the
terminal phase
Aim: COMFORT
PREVIOUSLY
ESSENTIAL
Consider stopping
NO LONGER
ESSENTIAL
Stop
Analgesics
Steroids consider
tapering
Antihypertensives
Antiemetics
Replacement
hormones
Antidepressants
Sedatives
Hypoglycemics
Laxatives
Anxiolytics
Diuretics
Antiarrhythmics
Anticonvulsants
Anti-ulcer drugs
Anticoagulants
Long term antibiotics
Iron, vitamins
Route of
Administration
PO dose
Opoid
Morphine
Per orem
IV, SC
Per rectum
5-10 mg
Anticholinergic
Hyoscine-N
Butyl Bromide
(HNBB)
IV, SC, IM
10-20 mg
Class of drug
Antiemetic/
Anxiolytic
Haloperidol
SC, IM, IV
0.5 1 mg SC
1-5 mg IV
(usually 1.5 mg)
Tranquilizer Sedative
Midazolam
Diazepam
SC, IV
IV, IM, Per rectum
5-15 mg SC
2.5 10 mg IV
Antifungal
Nystatin Oral
suspension
Oxford Textbook of Palliative Medicine. 3rd Ed. p.1124
Management of symptoms
in the final days of life
BEHAVIOR
EXAMPLES
Facial Expressions
Verbalizations, Vocalizations
Body Movements
Changes in Interpersonal
Interactions,
Management of Pain
in the Terminal Phase
Pain is a subjective symptom.
Key components of assessment and
management of pain are unchanged in the final
days.
Decreased level of consciousness and/or
confusion affects the patients ability to report
pain
family and health care team should work together in
assessing comfort.
Management of Dyspnea
in the Terminal Phase
One of the most feared symptoms and is
extremely frightening to dying patients.
In the absence or unavailability of a definitive
treatment for the cause proper symptomatic
treatment should be given to assure comfort,
regardless of the cause
Management of Dyspnea
in the Terminal Phase
Some treatments applicable as palliative care
at an earlier stage are no longer appropriate
When death is imminent it is rarely justified to
drain either a pleural or a pericardial effusion.
continue treatment with antibiotics
decreased ventilatory
response to hypoxia
and hypercapnia
reduced oxygen
consumption at rest
Dose
Morphine
Oxycodone
Non-Pharmocologic
Interventions for Dyspnea
Elevating the head of the bed to a
comfortable height
Having a fan blowing cool air towards the
patient.
Oxygen support at 3-5 L/min
titrated to empirical effect rather than based
on a pulse oximeter
ROUTE
DOSAGE
LORAZEPAM *
0.52.0 mg
PO, SL,
mucosal,
or IV
DIAZEPAM
510 mg
PO, IV
Q1 h until settled
then dose routinely
Q68 h PRN
CLONAZEPAM
0.25 2.0 mg
PO
Q12 h
MIDAZOLAM
0.5 mg
IV then by
continuous SC
or IV infusion
Management of
Agitation and Delirium
85% of patients experience delirium in the last
weeks of life
46% present with agitation.
Manifestations:
restlessness, paranoia, and combativeness.
Management of
Agitation and Delirium
If death may be hours, or a day or two away,
there is no purpose served in attempting to
define and reverse possible cause/s of
delirium.
Except with hypoglycemia
can be both diagnosed, managed and treated
immediately.
Management of
Agitation and Delirium
DRUG
SC
LEVOMEPROMAZINE
2.5mg q 6-8
to 50mg q4
(intermittent dose)
HALOPERIDOL
0.5 mg q12
5mg q4
MIDAZOLAM
2.5mg q6-8h up to
5-10mg q4 h
PHENOBARBITAL
CONTINUOUS
INFUSION
SIDE EFFECTS
12.5-200mg
/24 h
Anti-cholinergic
effects to aggravate
delirium with
ongoing use
5-15mg/24 h
Not as sedating as
levomepromazine
20-100mg/24h
Used alone:
disinhibition and
increased
restlessness
(intermittent dose)
50-100mg q8,
adjusted empirically
to effect
200-400/24h
Non-pharmacologic management of
Agitation and Delirium
Continuity of care
Keeping familiar persons at the bedside
Limiting medication, room, and staff
changes
Limiting unnecessary catheterization
Avoiding restraints
Medications for
Retained Respiratory Secretions
Continuous
infusion
DRUG
SC
* HYOSCINE
HYDROBROMIDE
(SCOPOLAMINE)
0.3-0.6 mg
q2/ prn
HYOSCINE-NBUTYLBROMIDE
(HNBB)
20 mg stat
60-90 mg
0.2 -0.4 mg
q4 / prn
indicate a poor
response
intermittent
dosing
* GLYCOPYROLATE
ATROPINE 1%
EYE DROPS
0.6-2.4 mg /24h
or higher
EFFECT
SYMPTOM CRISIS
IN THE END OF LIFE
Sudden development of symptom distress during
the final phase of illness.
May represent a fatal event.
Complications of crisis occur in individuals with a
known vulnerability for them
May leave unforgettable images that will add to
grief for months-years to come.
SYMPTOM CRISIS
IN THE END OF LIFE
Planning is crucial
Discuss clearly and openly with caregivers and
family members
Management of potential crisis thru proper
information and education
Capacity/capability to manage symptom crisis as it
arises.
Especially for those who opt for home care.
FAMILY SUPPORT
IN THE TERMINAL PHASE
AS DEATH APPROACHES
Ideally rapport has been established
with the patient and family members/
caregivers
Ideally advanced care plans have been
properly and thoroughly discussed
Wishes of the patient with regards to
management
Wishes of the family in the circumstance that
the patient is unable to decide
In the Hospital...
THANK YOU!